Superman syndrome, also known as 47, XYY, is a condition classified as a chromosomal aneuploidy (which is an abnormality in chromosome structure and/or number) in which males have an additional Y ...

Methods: The study included 371,211 Medicare Part A beneficiaries aged 65 and older with stroke, admitted to United States (US) IRFs between January 1, 2002 and June 30, 2007. Descriptive statistics ...

Travis Hunter made no secret about his intentions of playing both ways in the NFL after doing so during his decorated college career.The Heisman winner remains on track to do just that during his ...

Ashton Jeanty is on a mission to prove to the Las Vegas Raiders that they nailed their No. 6 pick overall in the 2025 NFL Draft, when they selected the superstar player out of Bois ...

Hunter Syndrome affects an estimated 0.38 to 1.09 per 100,000 live male births, given its X-linked inheritance pattern. Despite its rarity, the burden on affected individuals and families is ...

The passion for Hunter can't be taught and here's what his teammates are saying via ESPN. "He has a lot of juice. He can run all day, has a lot of energy," quarterback Trevor Lawrence said.

Oesophageal atresia and/or tracheo-oesophageal fistula are relatively common malformations occurring in approximately 1 in 3500 births. In around half of the cases (syndromic oesophageal atresia), ...

Hunter Syndrome is an ultra-rare disease, with incidence rates estimated between 0.38 and 1.09 per 100,000 live male births globally. Due to its X-linked inheritance pattern, the disease primarily ...

Lynch syndrome (LS) is characterised by the development of colorectal cancer, endometrial cancer and various other cancers, and is caused by a mutation in one of the mismatch repair genes: MLH1, MSH2, ...

Solar Mosaic LLC, a provider of home solar loans that has private equity firm Warburg Pincus as a major backer, is planning to file for bankruptcy in the face of market uncertainty over federal ...

Explore REGENXBIO's RGX-121 gene therapy for Hunter syndrome, with an FDA decision due Nov 9, 2025. Click here to read my most recent analysis.